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BirefringenceThe interaction of two helical antimicrobial peptides, HPA3 and HPA3P with planar supported lipid
membranes was quantitatively analysed using two complementary optical biosensors. The peptides are
analogues of Hp(2–20) derived from the N-terminus of Helicobacter pylori ribosomal protein L1 (RpL1). The
binding of these two peptide analogues to zwitterionic dimyristoyl-phosphatidylcholine (DMPC) and
negatively charged membranes composed of DMPC/dimyristoylphosphatidylglycerol (DMPG) (4:1) was
determined using surface plasmon resonance (SPR) and dual polarisation interferometry (DPI). Using SPR
analysis, it was shown that the proline substitution in HPA3P resulted in much lower binding for both
zwitterionic and anionic membranes than HPA3. Structural changes in the planar DMPC and DMPC/DMPG
(4:1) bilayers induced by the binding of both Hp(2–20) analogues were then resolved in real-time with DPI.
The overall process of peptide-induced changes in membrane structure was analysed by the real-time
changes in bound peptide mass as a function of bilayer birefringence. The insertion of both HPA3 and HPA3P
into the supported lipid bilayers resulted in a decrease in birefringence with increasing amounts of bound
peptide which reﬂects a decrease in the order of the bilayer. The binding of HPA3 to each membrane was
associated with a higher level of bound peptide and greater membrane lipid disordering and a faster and
higher degree of insertion into the membrane than HPA3P. Furthermore, the binding of both HPA3 and
HPA3P to negatively charged DMPC/DMPG bilayers also leads to a greater disruption of the lipid ordering.
These results demonstrate the geometrical changes in the membrane upon peptide insertion and the extent
of membrane structural changes can be obtained quantitatively. Moreover, monitoring the effect of peptides
on a structurally characterised bilayer has provided further insight into the role of membrane structure
changes in the molecular basis of peptide selectivity and activity and may assist in deﬁning the mode of
antimicrobial action.+61 3 9902 9500.
(M.-I. Aguilar).
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Recognition of the growing threat of drug resistant microbial
infection as one of the world's most pressing public health problems
has reinforced the urgent need for the development of new and more
effective antimicrobial agents [1–3]. Short cationic amphiphilic pep-
tides with antimicrobial and/or immunomodulatory activities are
being increasingly considered as potential candidates in the develop-
ment of a new generation of anti-infective therapeutic agents [4–6].
Central to these challenges is the analysis of the structure–function
relationships of various antimicrobial peptides, which have estab-lished a number of speciﬁc peptide conformation/composition and
activity criteria that can be incorporated into the design and synthesis
of effective broad-spectrum antimicrobial peptide drugs [7,8]. In
particular, these studies have helped to identify parameters that are
required for optimal peptide activity [9–14]. Several critical peptide
characteristics that affect antimicrobial peptide activity and speciﬁcity
include the sequence/length, charge, conformation, hydrophobicity
and amphipathicity of the peptides. Moreover, the composition,
charge, and domain structure of lipid membranes are important in
directing the selectivity toward speciﬁc microorganisms although
these parameters are less well understood. While the diversity in the
characteristics of antimicrobial peptides is also manifested in their
diverse mechanisms of action [7,8,15–18], the precise mechanism
of action is still challenging to deﬁne for a speciﬁc peptide. Impor-
tantly, the exact nature of how antimicrobial peptides selectively
kill their microbial targets requires an understanding of the relative
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the membrane to the overall microbicidal mechanisms. However
while the interaction between antimicrobial peptides and microbial
cell membranes has been widely accepted to be a critical step in
peptide action, there is very little information on the real-time
dynamic changes in the membrane structure during peptide binding.
Hp(2–20) (AKKVFKRLEKLFSKIQNDK), a cecropin-like antimicro-
bial peptide derived from the N-terminus of Helicobacter pylori ribo-
somal protein L1 (RpL1), possesses a broad-spectrum activity against
bacteria, fungi and protozoa at low micromole concentration without
causing haemolysis [19–21]. In addition to their pro-inﬂammatory
role as a monocyte chemoattractant [22,23], various analogues of Hp
(2–20) have been designed and synthesised in an attempt to enhance
its antimicrobial activity [24–28]. The importance of various structural
characteristics of Hp(2–20), including sequence, length, conformation
and amphipathicity/hydrophobicity on the antimicrobial activity
has been assayed via antifungal, antibacterial and haemolytic tests
[25,29] of a range of peptide analogues. One such Hp(2–20) analogue,
namely HPA3 which has a double substitution of Q17W and D19W,
showed 4–16 fold increased activity against bacteria and 2–4 fold
higher potency at inhibiting fungal growth [24,26]. Such enhanced
antimicrobial activity was attributed to the higher overall hydropho-
bicity and amphipathicity and longer linear helical structure as deter-
mined by CD and NMR spectroscopy in membrane-mimetic
environments [25,26]. The cytolytic activity of HPA3 towards bacteria
and yeast also correlated with an enhanced rate of ﬂuorescence-dye
leakage from artiﬁcial liposomes. Moreover, the correlation of the dye
leakage experiments and K+-release tests conducted on C. albicans
demonstrated that HPA3 exerts its enhanced antimicrobial activity
through peptide-induced pores with a diameter between 3.3 and
4.8 nm [26]. In addition, reproducible values of single-channel con-
ductance of multimeric membrane-defects formed by HPA3 in
zwitterionic lipid membranes at various holding potentials also sup-
port the existence of transmembrane pores [30,31]. However, in spite
this extensive cytolytic data, little is known about the membrane
binding characteristics of HPA3 and the role of different membrane
components in the activity of the HPA3-related peptides.
Since the HPA3 peptides have been shown to form pores, they are
likely to cause signiﬁcant effects on the membrane bilayer structure.
Thus, in order to unravel the mechanism of action, it is crucial to
characterise the modulating effects on the membrane structure
throughout the process of peptide binding leading to insertion. Dual
polarisation interferometry (DPI) is a recently developed optical
technique for real-time monitoring of thin layer deposition which can
be applied to liposome adsorption, deformation and bilayer formation
on a planar silicon oxynitride chip [32–36]. By simultaneously mea-
suring the mass and thickness or density, it is possible to obtain the
global structural (optogeometrical) properties of an adsorbed layer. In
addition to the sub-nanometre accuracy provided by DPI, membrane
birefringence [32] can also be determined to follow the process of
supported lipid bilayer formation. Birefringence quantiﬁes the degree
of alignment of the lipid molecules to the planar surface and the
uniaxial packing and ordering of the membrane lipids which can
provide a unique insight into the process of bilayer formation and the
changes in the packing and ordering of the membrane bilayer upon
peptide binding [32,37–41].
In the present study, the effect of the proline substitution on the
peptide structure and binding characteristics to membranes were
investigated using CD and surface plasmon resonance (SPR) and DPI
biosensor technology. DMPC, a neutral phospholipid was used as a
model for eukaryotic cell membranes, since PC-containing phospho-
lipids are virtually absent in bacterial membranes but are generally
found as the most abundant phospholipids in fungi, yeast and mam-
malian cells [42]. Phosphatidylglycerols (PGs) are less abundant in
eukaryotic plasma membranes but are found as the major component
in bacterial membranes, particularly in Gram-positive bacteria [42].Thus, it is also important to investigate the role of negatively charged
DMPG phospholipids in mediating the structure and membrane
binding-destabilisation effects of the Hp(2–20) peptide analogues. In
addition, DMPC and DMPG both contain fully saturated acyl chains
which allow the effect of disordering by peptides to be unaffected by
the properties of unsaturated double bonds. The effect of peptide
binding/insertion on the phase transition of lipid membranes was
also examined. These results have provided new insight into peptide
selectivity and dynamic process of insertion mechanisms in terms of
changes in the geometrical structure and lipid order of the membrane
bilayer and correlated the results with pore formation and the
bactericidal activity of the peptide.2. Materials and methods
2.1. Materials
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-
dimyristoyl-sn-glycero-3-[phosphor-rac-(1-glycerol)] sodium salt
(DMPG) were obtained from Avanti Polar Lipids (Alabaster, AL). All
chemicals used were of analytical grade. 4-Morpholinepropanesulfo-
nic acid (MOPS), sodium phosphate monobasic (NaH2PO4), sodium
phosphate dibasic (Na2HPO4), sodium chloride, calcium chloride and
sodium dodecylsulfonate (SDS) were purchased from Sigma-Aldrich
(St. Louis, MO). Chloroform, methanol and ethanol were all HPLC
grade purchased from Merck (Darmstadt, Germany). Hellmanex II
was purchased from Hellma (Müllheim, Germany). Water was
quartz-distilled and deionised in a Milli-Q system equipped with UV
oxidation to remove organic residue (Millipore Bedford, MA, USA).2.2. Peptide synthesis
Peptides were synthesised by solid phase methods using Fmoc-
(9-ﬂorenyl-methoxycarbonyl)-chemistry. The peptides were puriﬁed
using a preparative reversed phase C18 column (19×300 mm, 15 um,
Deltapak C18, Waters) using an appropriate 0–60% 0.1% triﬂuoroacetic
acid-acetonitrile gradient. Peptide purity was analysed using an
analytical reversed phase C18 column (4.6×250 mm, 5 um, 300 Å,
Vydac). The puriﬁed peptides were further characterised by amino acid
composition analysis and matrix-assisted laser desorption ionisation
(MALDI) mass spectrometer. Peptide concentrationwas determined by
amino acid analysis.2.3. Liposome preparation
2 mM DMPC stock in chloroform and 2 mM DMPG stock in
chloroform/methanol (3:1) were used for the preparation of dried
DMPC and DMPC/DMPG (molar ratio 4:1) ﬁlms. The stock solutions
were aliquoted out to the bottom of clean glass tubes tomake the total
lipid amount of 0.8 μmol. The solvent was then evaporated under a
gentle stream of N2 gas. The dried lipid ﬁlms were further vacuum
dried overnight to completely remove the residual organic solvent.
The dried lipid thin ﬁlms were hydratedwith a running buffer, 10 mM
MOPS, pH 7.0, 150 mM NaCl to make a lipid concentration of 1 mM.
Hydration was kept at 37 °C for 1.5 h with constant vortexing. The
hydrated lipid suspensionwas then sonicated in a 37 °Cwater bath for
30 min. The clear liposome solution was then extruded through a
50 nm polycarbonate membrane 21 times using an AVESTIN Liposo-
fast extruder (Avestin, ON, Canada). The size distribution of resulting
small unilamellar vesicles (SUVs) was characterised by dynamic light
scattering with a Malvern Zetasizer 3000 using a 5 mW HeNe laser
and the Windows PCS version 1.31 software (Malvern Laboratories
Ltd., Malvern, UK).
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CD experiments were performed using a Jasco 815 spectro-
polarimeter (Jasco, MD, USA) using a 0.1 cm path length quartz cell.
All spectra were obtained at 20 °C. DMPC and DMPC/DMPG (4:1)
small unilamellar vesicles prepared by hydrating in 10 mM sodium
phosphate buffer, pH 7.4 and were extruded through a polycarbonate
ﬁlter (100 nm pore diameter). The peptide (1 mM in sodium phos-
phate buffer) was then added to the liposome solution at a ﬁnal
peptide concentration of 20 μM resulting in a peptide:lipidmolar ratio
of 1:50. The peptide–liposome solution was mixed by inversion and
incubated for 2 min. Each spectrum was obtained by averaging ﬁve
scans in the 190–260 nm wavelength range. All CD spectra are re-
ported in mean residue ellipticity [θ] in deg cm2dmol−1. Theα-helical
content was calculated from the mean residue ellipticities at 222 nm
([θ]222) according to
% α½  = θ½ 222
θ½ helix  1−2:57 = nð Þ
  × 100 ð1Þ
where [θ]helix is the ellipticity of a peptide of inﬁnite length with 100%
helix with a value of−39,500 deg cm2dmol−1, and n is the number of
residues in each peptide.
2.5. Surface plasmon resonance (SPR)
SPR experiments were carried out with a Biacore T100 analytical
systemwith an L1 sensor chip (Biacore, Uppsala, Sweden). The system
was cleaned using the standard Desorb and Sanitize protocol with a
maintenance chip and then allowed to run overnight with water. The
L1 chip was docked and ﬁrst washed with an injection of 5 μL of
20 mM CHAPS at a ﬂow rate of 5 μL/min to clean the chip surface.
Prior to the liposome immobilisation, the temperature was adjusted
to 20 °C. SUVs in immobilisation buffer (10 mM MOPS pH 7.0,
150 mM) were injected at a ﬂow rate of 2 μL/min for 40 min. At the
end of liposome injection, 30 μL of 10 mM NaOH was injected at
50 μL/min. All solutions were freshly prepared, degassed and ﬁltered
through a 0.22 μm nylon membrane ﬁlter. In our experiments lipid
deposition led to deposition levels above 5000 RU for all lipid
mixtures which suggests that the lipid surface has a similar bilayer
structure in each case indicating an optimum surface coverage.
The peptide solutions were prepared by dissolving HPA3 and
HPA3P in the running buffer for a 100 μM peptide stock. Peptide
solutions at eight concentrations ranging from 0.1 μM to 20 μM were
prepared from the peptide stock 1 mM. 100 μL of each peptide
solution was injected at a ﬂow rate of 30 mL/min having a total
injection of 200 s. On completion of injection, buffer ﬂow continued to
allow a dissociation time of at least 600 s. All binding experiments
were carried out at 20 °C. The afﬁnity of the HPA3 and HPA3P to the
membrane binding event was determined from a series of response
curves for each set of peptide−membrane combinations.
2.6. Kinetic and afﬁnity constant calculation
The sensorgrams for each peptide−membrane interaction were
analysed by numerical integration curve-ﬁtting algorithm [43,44].
The BIAevaluation 3.0 software (Biacore, GE Health) provides dif-
ferent reaction models to perform complete kinetic analysis of the
peptide−membrane interaction. On the basis of the possible binding
mechanisms of Hp(2−20) peptides to the membrane, a two-state
reaction model was chosen for the estimates for kinetic constants
including the association (ka) and dissociation (kd) rate constants and
afﬁnity constants [43,45]. The resultant sensorgrams of each peptide
were ﬁt locally to the RUmax obtained at 0.1−20 μM.2.7. Dual polarisation interferometry
Dual polarisation interferometry (DPI) is an analytical method for
analysing thin ﬁlms using a dual optical waveguide interferometric
technique. Alternate dual orthogonal polarisation allows unique com-
binations of several optogeometrical properties including refractive
index (RI), density, thickness, mass and birefringence to be measured
in real-time for the formation of biomolecule layers.
DPI, as deployed in the Analight BIO200 (Farﬁeld Group Ltd.,
Manchester, UK), consists of a dual slab waveguide sensor chip with
an upper sensing waveguide and a lower optical reference wave-
guide illuminated with an alternating polarised laser beam (HeNe,
wavelength 632.8 nm). As shown schematically in Fig. 1A, the sensor
chip comprises four layers of deposited silicon oxynitride on a silicon
wafer surface. Two orthogonal polarizations are passed through
the sensor chip creating two different waveguide modes, namely
transverse electric (TE) and transverse magnetic (TM) waveguide
modes. Each TM and TEmode generates an evanescent ﬁeld from the
top sensing waveguide surface interacting with materials coming
into contact with the sensor surface and resulting in a change in
refractive index. When this occurs the phase difference between the
sensing waveguide and the buried reference waveguide is altered
and the position of the interference fringes changes. In this way the
sensor is capable of measuring very subtle molecular changes that
occur on the sensor surface. The interference fringe pattern for each
TM and TE waveguide mode shown as the diffraction fringe image,
illuminates a 1024×1024 element-imaging device in the far-ﬁeld,
the output of which is passed to the digital signal processing unit. The
relative phase position is updated every 2 ms using a spatial Fourier
transform method. Two separate measurements of fringe shift TM
and TE data are transferred to a personal computer for further
analysis to provide a real-time data display and to further resolve
the data into thickness and refractive index values for the growing
layer.
Unmodiﬁed silicon oxynitride FB80 AnaChips (Farﬁeld Group,
UK) were used for the preparation of a supported lipid bilayer (SLB).
The sensor chip (dimensions 24×6 mm) is clamped inside a dual-
zone temperature-controlled housing capable of controlling chip
temperature by a Peltier system to within ±0.005 °C. A 100 μm
thick ﬂuorosilicon mask with two slots is clamped on top of the
waveguide chip which provides two separate microﬂuidic channels
over the sensing waveguide. Each ﬂow channel has a dimension
of 1 mm wide and 17 mm long which forms a 1.7 μL measurement
chamber.
These chips were cleaned on-line by rinsing 3 times with 10%
Hellmanex II followed by 3 times with 2% SDS and ﬁnally rinsing 3
times with absolute ethanol. Prior to measurement, the waveguide
chips were calibrated with respect to their optical properties using an
80:20 w/w ethanol/water mixture at 20 °C. All experiments were
conducted in 10 mMMOPS pH 7.0, 150 mM NaCl. The ﬂow rate of the
running buffer was controlled using a Harvard Apparatus PHD2000
programmable syringe pump. Typical ﬂow rates were 20 μL/min for
liposome deposition and 40 μL/min for peptide binding to the SLB.
AnaLight200 version 2.1.0 software was used for data acquisition
and the acquired data were analysed using AnaLight® Explorer prop-
rietary software. Data were acquired at 10 Hz and averaged to give an
output of one data point per second.
2.7.1. Supported lipid bilayer formation
Liposome solutions (0.1 mg/mL) of DMPC and DMPC/DMPG
(4:1) were injected in the presence of 1 mM CaCl2 for 10 min
at 20 μL/min at 28 °C. The adsorption was immediately followed
by injecting 1 mM CaCl2 in the running buffer for 10 min which
facilitates the stabilisation of the SLB on the solid substrate.
The SLB was further equilibrated in the running buffer without
Ca2+ for 20 min before adjusting the temperature to 20 °C. The
Fig. 1. (A) Biomembrane chip with dual polarisation interferometer (DPI) consists of a dual slab waveguide guiding light through two high-refractive index structure (sensing
waveguide and reference waveguide). Two orthogonal polarisations, TM and TE, pass through the waveguide forming two evanescent ﬁelds which are affected by the molecules
binding onto the surface. Such changes for each TM and TE are detected separately as a phase shift in the fringe pattern at the far-ﬁeld. Thus, the formation of a unilamellar planar
bilayer via liposome adsorption and the dynamic impact of peptide binding on the lipid bilayer structure can be quantitatively analysed in real-time. (B) The optical birefringence
(Δnf) of a fully aligned/ordered (top) and a disordered (bottom) unilamellar supported lipid bilayer. The molecular refractive index (RI) in x (nx) and y (ny) horizontal
dimensions is different from RI in the z vertical dimension (nz). Birefringence is a measure of the difference between RI parallel with surface (ne) and RI perpendicular to surface
(no). Thus, the changes in the packing, alignment and degree of order of lipid molecules assembled on the surface can be determined from quantitatively analysing changes in
birefringence.
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of 50 μg/mL BSA. A full lipid bilayer-covered silicon oxynitride chip
was conﬁrmed by the absence of BSA binding to the membrane
bilayer.2.7.2. Peptide injection
HPA3 and HPA3P were prepared at concentrations of 5 µM, 10 µM,
and 20 µM in 10 mM MOPS, pH 7, 150 mM NaCl. Peptide samples
were injected consecutively in order of increasing concentration onto
the deposited bilayer at 20 °C. 180 μL of each peptide concentration
was injected at a ﬂow rate of 40 µL/min, followed by running buffer
for 30 min prior to injecting the next concentration onto the same
bilayer surface. Each peptide concentration measurement was
performed on the same lipid bilayer, after which the waveguide
surface was regeneratedwith 2% SDS, 10% Hellmanex II and ethanol at
28 °C.2.7.3. Optical birefringence analysis for the dynamic changes in
membrane lipid order
Birefringence (optical anisotropy) is a measure of the difference in
refractive index of two orthogonal polarisations [37,40,41]. Among
various types of thin ﬁlms, phospholipid bilayers show optical
birefringence owing to the liquid crystal properties of lipid molecules
self-assembled into uniaxial aligned bilayers. As shown in Fig. 1B, top,
the non-random orientation of lipid molecules in a membrane creates
an anisotropic system with a uniaxial optical axis with two principal
refractive indices, namely, the extraordinary refractive index (ne)
which denotes the electric vector polarised parallel to the optical axis,
and the ordinary refractive index (no) which denotes the electric
vector polarised perpendicular to the optical axis. The difference
between these two refractive indices for a lipid ﬁlm is deﬁned as the
birefringence Δnf as the following,
Δnf = ne−no: ð2Þ
Fig. 2. CD spectra of (A) 20 μM HPA3 and (B) HPA3P in 10 mM sodium phosphate
buffer, pH 7.4 (grey line), 1 mM DMPC (blue line) and 1 mM DMPC/DMPG (4:1)
liposomes (red line).
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interoferometry through calculating the difference between the two
effective refractive indices, namely refractive index of transverse
magnetic (TM) waveguide mode (nTM) and refractive index of trans-
verse electric (TE) waveguide mode (nTE). The degree of molecular
order, S, of the uniaxial lipid bilayer is deﬁned by the ratio of the
principal polarizabilities of the bilayer to themolecular polarizabilities
[40]. This order parameter (S) is proportional to the birefringence
values. Thus, the birefringence values represent an averaged mea-
surement of lipid molecular orientation order and the lipid acyl chain
order. As shown in Fig. 1B, high Δnf values are obtained for a fully
aligned lipid bilayer whereas low Δnf indicates a randomly ordered
lipid bilayer.
The effective birefringence (nTM−nTE) can only be determined by
calculating the two different refractive indices, nTM and nTE for each
waveguide mode by ﬁxing the thickness or RI of the deposited layer
and assuming a uniform layer coverage. The nTM is affected by the
layer thickness and both ne and no as follows,
nTM =
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n2e sin
2θ + n2ocos
2θ
q
ð3Þ
where θ, the mode angle denotes the angle between the optical axis of
the adlayer and the mean path of the two wave mode as shown in
Fig. 1B, top, while the nTE is affected only by the layer thickness and no
as
nTE = no ð4Þ
According to Eqs. (3) and (4), both ne and no can be calculated from
nTM and nTE.
The respective effective adlayer nTM and nTE corresponding to the
measured TM and TE phase changes are calculated by ﬁtting the data
to a waveguide equation [32]. When a correct thickness is used for an
anisotropic layer, the difference between the nTM and nTE will be the
true effective birefringence of the adlayer [46]. For deposition of a
lipid bilayer, a constant thickness is assumed for the entire process
[32], corresponding to the steric thickness obtained by neutron scat-
tering and X-ray reﬂectivity. For the purposes of the present study, an
assumed thickness for both the DMPC and DMPC/DMPG layer was
ﬁxed at the 4.6 nm for the supported lipid bilayer formation at 20 °C
[47,48]. When the thickness is ﬁxed for an anisotropic lipid bilayer,
changes in refractive index (RI) and therefore density andmass can be
further calculated for the supported lipid bilayer. Similarly, changes in
the thickness of the deposited bilayer can also be resolved by ﬁxing
the refractive index at a predetermined value of 1.47 for DMPC and
DMPG.
2.7.4. Calculation of mass for an anisotropic layer
To calculate the mass of an adsorbed molecular layer from DPI
measurements, de Feijter formula was employed. The mass of lipid
bilayer (mlipid) formed on the solid support is calculated as follows:
mlipid = d niso−nbufferð Þ= dn=dcð Þlipid ð5Þ
and the mass of peptides (mpeptide) bound to the lipid bilayer is
calculated as follows:
mpeptide = d niso−nbufferð Þ= dn=dcð Þpeptide ð6Þ
where niso denotes the average or corresponding isotropic refractive
index of the adlayer and is calculated according to
niso =
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n2TM + 2n
2
TE
 
= 3
q
ð7Þ
and nbuffer is the refractive index of the MOPS buffer used for these
experiments which was obtained experimentally as nbuffer=1.3349(T=20 °C). The dn/dc is the speciﬁc refractive index increment of the
adlyer. The de Feijter formula assumes that dn/dc remains constant
throughout the whole process of the experiment. For the present
analysis, the dn/dc values of 0.135 mL/g and 0.182 mL/g were used
for lipids and peptides, respectively [32].3. Results
3.1. Peptide secondary structure determined by circular dichroism (CD)
The effect of proline substitution on the secondary structure of
HPA3 in aqueous buffer and lipid media was examined with CD and
the resulting spectra for HPA3 and HPA3P shown in Fig. 2A and B
respectively. In 10 mM sodium phosphate buffer (pH 7.4), 20 μM
HPA3 and HPA3P (sequences listed in Table 1) showed CD spectra
with a single minimum at about 198 nm which is characteristic for an
extended structure (grey line). In the presence of DMPC liposomes,
the spectrum showed a single maximum at 190–195 nm and a double
minimumat 205 and around 220 nmwhich indicated the formation of
α-helical conformation. This corresponded to a calculated % helix of
11.1% for HPA3 (Fig. 3A, red line) while negligible secondary structure
was observed for HPA3P with 2.4% helix in DMPC media (Fig. 3B, red
line). However, in the presence of DMPC/DMPG (4:1) liposomes, both
HPA3 and HPA3P adopted helical structure. The percentage of helicity
obtained for HPA3 in DMPC/DMPG was 26.2% which is higher than
the helix content obtained for HPA3P (14.3%) in the same lipid media.
Overall, these results show that the proline substitution at the middle
of HPA3 peptide caused a marked reduction in helix formation in a
membrane environment.
Table 1
The molecular weight, net charge and sequences of antimicrobial peptides binding to planar solid-supported membranes.
No. Peptides M.W. Charge Sequence
1 HPA3 2448.20 +6 A K K V F K R L E K L F S K I W N W K
2 HPA3P 2417.20 +7 A K K V F K R L P K L F S K I W N W K
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The binding of HPA3 and HPA3P to zwitterionic DMPC and anionic
DMPC/DMPG (4:1) bilayers was measured in real-time by SPR and
sensorgrams obtained at eight different peptides concentrations
between 0.1 and 20 μM are shown in Fig. 3. The dependence of the
RU on the peptide concentration at the end of the injection at 200 s
indicates that the amount of peptide bound to lipids is approximately
proportional to the injected peptide concentration between 2.5 and
20 μM. However, no signiﬁcant change in response was observed for
these peptides at lower concentrations between 0.1 and 0.5 μM. Thus,
a minimum peptide concentration of 0.5 μM was required for the
interaction and effects on the membrane to be analysed.
HPA3 readily adsorbed onto the DMPC bilayer, giving very high RU
values with a RUmax of 4780 RU at 20 µM. These values were sig-
niﬁcantly higher than the RU values observed for the binding of
HPA3P to DMPC (RUmax of 1250 RU at 20 µM HPA3P). The role
of negatively charged lipids in peptide binding was also analysed.
Again, a higher response was observed for HPA3 than for HPA3P on
DMPC/DMPG. However, there was little difference between the
RUmax for each peptide bound to zwitterionic DMPC compared to
anionic DMPC/DMPG membranes demonstrating that the potential
increase in electrostatic interactions with the additional 20% anionicFig. 3. SPR sensorgrams of Hp(2–20) analogues binding to DMPC and DMPC/DMPG (4:1) me
to DMPC, (B) HPA3P to DMPC, (C) HPA3 to DMPC/DMPG and (D) HPA3P to DMPC/DMPG.DMPG did not occur. Overall, the binding of HPA3 to both DMPC and
DMPC/DMPG exhibited a 4-fold increase in RUmax relative to HPA3P.
The higher RUmax of HPA3 obtained for both DMPC and DMPC/DMPG
can be correlated with a greater exposure of the hydrophobic surface
as reﬂected by the longer retention time of HPA3 when analysed by
C18 RP-HPLC (3.6 min later than HPA3P on a 0–50% acetonitrile
gradient over 30 min). Thus, the proline substitution not only lowered
the overall hydrophobicity but also reduced membrane binding.
As the binding did not reach equilibrium during the association
phase, the afﬁnity constants could not be calculated from the depen-
dence of RUmax and peptide concentrations by ﬁtting the data to a
steady-state afﬁnity model [43,45]. Curve-ﬁtting of sensorgrams to a
two-state reaction model was thus performed in order to obtain
quantitative information on the afﬁnity and the kinetic rate constant
of the binding. However, high χ2 values (i.e. >700) were obtained
indicating signiﬁcant deviation from the two-state model of peptide–
membrane interaction.
3.3. DPI measurement of Hp(2–20) analogues binding to lipid membranes
3.3.1. Characterisation of the deposited lipid bilayer
The formation of a homogeneous, defect-free and fully aligned
supported lipid bilayer is crucial in acquiring accurate quantitativembranes. Peptides were injected at a concentration ranging from 0.1 to 20 μM. (A) HPA3
Table 2
Structural parameters of a unilamellar phospholipid bilayer formed via direct adsorption of small unilamellar vesicles (50 nm SUVs) onto a planar silicon oxynitride.
Lipid RIa Densitya (g/cm3) Thicknessb (Å) Mass (ng/mm2) Birefringence Area (Å2/lipid)
DMPC (n=8) 1.4663±0.0019 0.97±0.01 44.7±0.7 4.48±0.06 0.0215±0.0007 50.29±0.73
DMPC/DMPG (4:1) (n=8) 1.4747±0.0046 1.04±0.04 47.6±1.6 4.77±0.16 0.0235±0.0015 47.44±1.59
a The isotropic refractive index and density were calculated using the ﬁxed thickness of 4.6 nm for DMPC and DMPC/DMPG at 20 °C as determined by neutron scattering [47,50].
b The thickness is calculated using the ﬁxed isotropic refractive index of the lipid ﬁlm of 1.47 [32].
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(2–20) peptide analogues. The structural characteristics obtained for
the planar DMPC and DMPC/DMPG bilayers formed via liposome
adsorption onto the planar silicon oxynitride are listed in Table 2. The
average values of the planar bilayer thickness obtained for DMPC and
DMPC/DMPG were 44.7 Å and 47.6 Å, respectively. Based on the
deposited mass per unit surface area, the surface area per lipid
molecule was also calculated for eachmembrane bilayer, and found to
be 50.3 Å2 and 47.4 Å2 for DMPC and DMPC/DMPG bilayer respec-
tively. These values correlate closely with the reported values ob-
tained from X-ray reﬂectivity and neutron reﬂectivity studies [47–50].
The structures for both membrane compositions were also highly
reproducible for all supported lipid bilayers formed at 20 °C, with the
standard deviations between lipid deposition being 1.2% and 3.3% for
DMPC and DMPC/DMPG, respectively. These consistent and homog-
enous membrane structures were then used for investigation of the
real-time binding of each peptide.
3.3.2. Binding of Hp(2–20) analogues to planar supported lipid bilayers
The dynamics of structural changes occurring within the aligned
unilamellar phospholipid bilayer upon the binding of HPA3 andFig. 4. Real-time TM and TE phase changes for the consecutive injection of 5, 10 and 20 μMpe
DMPC, (B) HPA3P to DMPC, (C) HPA3 to DMPC/DMPG and (D) HPA3P to DMPC/DMPG.HPA3P were then examined with simultaneous real-time measure-
ment of changes in TM/TE, mass and birefringence. For each binding
experiment, peptides were injected at 5, 10 and 20 μMaccumulatively
onto the same lipid bilayer. This concentration range was selected
from the upper concentrations which exhibited a linear dependence
of the RU on peptide concentration in the SPR experiments. It should
be noted that consecutive accumulative injections were performed.
That is, the 5 μM injection was made on a fresh membrane, while the
10 μM sample was injected onto the same surface which contained
residually bound peptide from the 5 μM injection. Similarly, the 20 μM
sample was injected onto the same surface following the 10 μM
injection. This experimental design was used to explore the effects of
accumulative exposure of the bilayer surface to each peptide. The
real-time TM and TE phase changes for HPA3 and HPA3P binding to
DMPC and DMPC/DMPG are shown in Fig. 4 and show signiﬁcant
differences between each peptide and each bilayer. In order to relate
these changes to more speciﬁc molecular parameters, the TM/TE
values were then used to calculate the corresponding real-time mass
changes and are shown in Fig. 5. There was a rapid increase in the
mass upon injection of both HPA3 (Fig. 5A and B) and HPA3P (Fig. 5C
and D) to both planar bilayers at 5 μM. However, for subsequentptide solution to a planar supported DMPC and DMPC/DMPG (4:1) bilayer. (A) HPA3 to
Fig. 5. Real-time mass changes for the consecutive injection of 5, 10 and 20 μM peptide solution to a planar supported DMPC and DMPC/DMPG (4:1) bilayer. (A) HPA3 to DMPC,
(B) HPA3P to DMPC, (C) HPA3 to DMPC/DMPG and (D) HPA3P to DMPC/DMPG.
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and mass was not proportional to the peptide concentration, as the
degree of change became smaller and smaller with the increase from 10
to 20 μM peptide. These results indicate that the accumulated peptide
injection did not result in further proportional increases in the amount
of peptide bound to the membrane. If the dissociation phase is then
analysed, there was a small decrease in mass at the end of injection for
both peptides at 5 μMwhich indicates a strong retention of the peptides
within the membrane at this low concentration. At the higher con-
centrations, therewas a smaller increase in the residually boundpeptide
as a higher proportion of the adsorbed peptide dissociated at the end of
the injection. This signiﬁcant level of residually bound peptidemay be a
consequence of irreversible insertion of peptides into the bilayer [51]
and is qualitatively consistent with the SPR data.
3.3.3. Effect of Hp(2–20) analogues on membrane lipid ordering as
indicated by birefringence
The changes in the value of mass and birefringence for both the
DMPC and DMPC/DMPG bilayers at the end of each peptide injection
at 5, 10, and 20 μMare plotted in Fig. 6. Fig. 6A summarises the end-of-
injection data derived from Fig. 5 and shows HPA3 bound to a greater
extent on both lipids than HPA3P in which the mass was 1.4 fold
higher and 1.8 fold higher for HPA3 than HPA3P with DMPC and
DMPC/DMPG, respectively. In addition, the data shows that both
peptides bound more on the DMPC/DMPG mixed bilayers than the
DMPC bilayer. While this appears a larger difference when compared
to the SPR data shown in Fig. 4, each peptide injection was made on a
fresh membrane surface in the SPR experiments, in contrast to the
accumulative injection protocol used in the DPI experiments. It is
interesting to note that the difference in the SPR response for eachpeptide on different bilayers is less than the mass changes observed
in the DPI analysis. The structure of the bilayer on the DPI chip is
very precisely determined — while the liposome structure on the
SPR chip may be comprised of unruptured liposomes together with
some multilayer bilayers. It is possible that these differences lead to
differences in the amount of peptide that can bind per/unit area of
bilayer surface.
Birefringence is a quantitative measure of the membrane order
[32,38,40,41] and birefringence values were determined as described
in the Materials and methods. A decrease in the birefringence
correlates with a decrease in the order or an increase in the disorder
of the membrane packing and is therefore a sensitive probe of the
overall integrity of the membrane structure. HPA3 induced greater
changes in membrane structure than HPA3P on both supported
bilayers, as shown in Fig. 6B, where more pronounced decreases in
birefringence were observed for HPA3 than HPA3P binding to both
lipid bilayers. In addition, the binding of HPA3 and HPA3P to the
anionic DMPC/DMPG bilayer caused much larger decreases in
birefringence than for DMPC as evident by 2.0 fold and 2.4 fold
decreases in DMPC/DMPG birefringence for HPA3 and HPA3P re-
spectively. This result indicates that the DMPC/DMPG bilayer, which
is initially more tightly packed, becomes more disordered than the
DMPC bilayer as a result of initial peptide binding at 5 μM. However,
subsequent accumulated addition of peptide to the bilayer did not
result in signiﬁcant further decreases in the birefringence and mass.
Overall, these mass and birefringence results suggest that HPA3P
induces a greater disordering of the DMPC/DMPG bilayer per unit
peptide mass than HPA3, most likely due to the presence of the
proline residue that causes a bend in the helical structure which in
turn disrupts the aligned lipid bilayer.
Fig. 6. Hp(2–20) analogues, HPA3 (circle) and HPA3P (square), induced changes in the
(A) mass and (B) birefringence of planar supported DMPC (solid line) and DMPC/
DMPG (4:1) (dash line) bilayer for 5, 10, and 20 μM peptide concentration.
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peptide mass can be further examined by the plot of bilayer
birefringence versus peptide mass as shown in Fig. 7. The binding
of these peptides to both supported lipid bilayers resulted in de-
creases in birefringence at each concentration indicating a signiﬁcant
disordering in the lipidmolecules induced by the peptides. If the data
for HPA3 on DMPC is considered ﬁrst, it can be seen that at 5 μM,
there is a linear decrease in birefringence with increasing mass.
However, the birefringence and mass values do not return to the
initial values at the end of the injection indicating residually bound
peptide and permanent change to the membrane order. Upon the
10 μM and 20 μM injections, there is a further linear decrease in
birefringence, with the mass and birefringence values returning to
the post 5 μM values by the end of each injection. Such reversible
changes in birefringence indicated that the further addition of
peptide only resulted in transient changes in the lipid ordering and
that the bilayer can re-align after the peptide dissociates from the
bilayer. Similar birefringence-mass proﬁleswere observed for HPA3P
on DMPC, but smaller changes in birefringence were evident
reﬂecting a smaller perturbation of DMPC membrane structure by
HPA3P.
The overall magnitude of decreases in birefringence at 5 μM
was signiﬁcantly larger for both peptides on DMPC/DMPG. Regres-
sion analysis of the association of HPA3 and HPA3P was performed at
5 μM — the extent of birefringence changes as a function of peptide
mass was greater for their binding to DMPC/DMPG (−0.0075/ng/
mm2) than to DMPC (−0.0061/ng/mm2). These results reﬂect a
greater disruption of lipid packing to the DMPC/DMPG bilayer most
likely as a result of insertion into the membrane.3.3.4. The thermal phase transition of Hp(2–20) analogue-bound
membranes
The changes in birefringence as a function of temperature also
provide a sensitive tool to examine the impact of the HPA3 peptides
on the phase transition behaviour of the adsorbed DMPC and DMPC/
DMPG. As shown in Fig. 8, a distinctive phase transition (Tm) was
observed at 21.8 °C and 23.7 °C for pure DMPC and mixed DMPC/
DMPG bilayers respectively. Moreover, changes between the ordered
and disordered state of DMPC as determined by birefringence are
directly analogous to the phase transition between gel and liquid-
crystalline states determined by the excess heat capacity using DSC.
The data shown in Fig. 8 are thermal denaturation curves thereby
demonstrating the effects of the phase transition on the binding
characteristics of the peptide while the lipids undergo a change in
structure. Speciﬁcally, the birefringence values were 0.0215 for gel-
phase DMPC and 0.0235 for gel-phase DMPC/DMPG. In comparison,
the birefringence values were 0.0185 for liquid-crystalline DMPC and
0.0221 for liquid-crystalline DMPC/DMPG. The increase in Tm from
21.8 °C to 23.7 °C in the presence of the anionic lipid is consistent with
the phase behaviour examined by DSC [52,53] and reﬂects a higher
ordering for DMPC/DMPG which is also evident from a higher
birefringence value (Table 2).
This data can then be compared to the effect of bound peptide on
the shape of the transition and the value of the transition tempera-
ture. For DMPC, the birefringence dropped from 0.0215 to 0.02 upon
binding of each peptide. During heating, this value remained constant
(Fig. 8A) up to 22 °C and was then followed by a distinct phase
transition obtained at 24.5 °C. As the temperature increased further,
the subsequent decrease in birefringence was greater for the HPA3P–
DMPC complex (ﬁnal value=0.0176) than for HPA3–DMPC (ﬁnal
value=0.0183). In other words, HPA3P induced a greater degree of
change in thermal induced birefringence than HPA3. Thus, the HPA3-
bound DMPC still retained a certain degree of ordering while the
HPA3P-bound DMPC became more disordered and the distinctive
change in lipid phase transition was absent. This differencemay relate
to the differences in the helical structure and assembly and orien-
tation of peptides in the DMPC membrane.
Comparison with the effect of peptide binding to DMPC/DMPG
indicates that both peptides induced much greater disordering in the
mixed DMPC/DMPG bilayer. The birefringence value for DMPC/DMPG
dropped to 0.0180 upon binding of HPA3 and to 0.0187 for HPA3P
and then further decreased slightly with increases in temperature up
to around 25 °C. Above 25 °C, the birefringence values became very
similar for both peptides and unlike the peptide-bound DMPC bilayer,
the DMPC/DMPG bilayer exhibited no obvious transition over the
temperature range with either peptide. Such differences in the phase
behaviour between the two bilayers indicate that the ﬁnal structure of
the peptide-bound DMPC/DMPG bilayer is in amuchmore disordered
state than the bilayer alone. In other words, both peptides induce a
much greater degree of disorder in a DMPC/DMPG bilayer than in a
DMPC bilayer.
4. Discussion
The structural properties and dynamic motion of membranes have
been extensively studied with various spectroscopic and diffraction
methods [49,54,55]. In spite of the large variation in the lipid com-
positions found in natural membranes, structural parameters such as
lipid packing density, ripple structure, head group packing, thickness
and lipid surface area are only available for certain types of lipid
molecules [49,54,55]. In terms of peptide–membrane interactions,
the inability to fully characterise membrane structure prior to and
throughout the peptide binding-dissociation process has limited
our complete understanding of the role of membrane structure in
the molecular mechanisms of antimicrobial peptide action. The
speciﬁc interaction of peptides with different lipid components in a
Fig. 7. Hp(2–20) analogues induced changes in membrane lipid order as a function of membrane-bound peptide mass. (A) HPA3 to DMPC, (B) HPA3P to DMPC, (C) HPA3 to DMPC/
DMPG and (D) HPA3P to DMPC/DMPG.
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properties of a membrane. The subtle local perturbation in lipid
molecules may translate into changes in the global structural prop-
erties, such as membrane thinning/thickening and alterations in the
acyl chain packing and lipid surface area [56–59]. These changes
collectively affect the function of a membrane and subsequent cell
activity. The coherent changes in the structure and dynamic motion in
peptide and lipid molecules vary in duration and time scale [60].
Hence, greater emphasis is now required to examine the geometrical
and dynamic changes that occur within a lipid matrix associated with
peptide association–dissociation, insertion, and disruption of mem-
brane integrity. The aim of this study was to document the use of DPI
as a biophysical tool that quantiﬁes the effect of peptides on the extent
of membrane perturbation through measuring membrane order
(birefringence) in real-time as a function of peptide binding.
Hp(2–20) is a peptide derived from the N-terminus of H. pylori
ribosomal protein L1 and exhibits antimicrobial activity providing a
valuable lead candidate as a template for new antibiotics to overcome
the threat of drug resistance infection. Among various attempts to
enhance or optimise the antimicrobial activity without harming the
host cell, one analogue, the HPA3 peptide, with a double substitution
of Trp for Gln17 and Asp19, displayed enhanced antibiotic activity
without causing haemolysis [24,26]. This enhanced activity was
attributed to the increased amphipathicity and overall hydrophobic
properties of the linear helical HPA3 peptide. The structure of HPA3
was further modiﬁed by the substitution of a proline for a glutamate
which induces a bend at the centre of the helix. Previously, the
introduction of proline into Hp(2–20) caused a helical break with
higher ﬂexibility and signiﬁcantly reduced the antibiotic activity [61].
Although the preference of these peptides towards negatively chargedbacterial membranes has been shown by various cell or lipid vesicle-
based assays, little is known about the mechanisms and modes of
action employed by these peptides.
Among the wide range of membrane models, DMPC/DMPG
[52,62–71] and POPC/POPG [57,64,69,72–75] bilayers are the most
commonly used in studies of peptide–membrane interactions. DMPC/
DMPG membrane models were chosen in our study for the following
reasons: (1) DMPC and DMPG both contain fully saturated acyl chains
which allow the effect of disordering by peptides to be minimally
affected by the properties of unsaturated double bonds; (2) DMPC
and DMPG are extremely well characterised in terms of both physical
and structural properties which is important for the validation
and conﬁrmation of the high resolution structural data (i.e. thick-
ness±0.1 nm) generated in the DPI experiments; (3) Both DMPC and
DMPG have a gel to liquid-crystalline phase transition temperature
(Tm) of 23 °C while the Tm for POPC and POPG is −2 °C, a tem-
perature which makes it almost impossible to examine the effect of
peptide binding (insertion) on the thermal transition of lipid mem-
branes. These properties offer a signiﬁcant advantage over POPC/
POPG for examining the impact of peptide insertion on the thermal
transition of membrane. Moreover, PC-containing phospholipids are
the most abundant phospholipid in the eukaryotic membrane and are
generally accepted as a good model for the surface membrane of
mammalian cells. However, the lipid composition of microbial cells
varies from species to species and also changes with growing con-
ditions. Nevertheless, PG-containing lipids are the major lipids in
bacterial cell membranes, and particularly in Gram (+) bacteria. The
incorporation of DMPG molecules in model DMPC membrane
therefore mimics the bacterial cell membrane surface charge. HPA3
and HPA3P are highly positively charged (Table 1) and we therefore
Fig. 8. Effects of Hp(2–20) analogues on the thermal phase transition of adsorbed lipid
bilayers. The temperature induced changes to themolecular ordering is used tomonitor
the phase transition for the same membrane without peptides and post 20 μM peptide
binding. (A) Pure DMPC; (B) HPA3 (black) and HPA3P (grey) bound DMPC bilayer;
(C) pure DMPC/DMPG (4:1) and (D) HPA3 (black) and HPA3P (grey) bound DMPC/
DMPG (4:1) bilayer.
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and binding to these model membranes. The ratio of DMPC to DMPG
as 4:1was chosen as this mixture exhibits the highest phase transition
temperature of DMPC/DMPG mixtures [52].
In this study, we quantitatively analysed the membrane binding
of these peptides using two optical biosensors to provide information
on the relative binding and changes in the membrane structure upon
binding. The formation of secondary structure in peptides is a pre-
requisite step towards membrane interaction and the degree of
secondary structure also impacts on the insertion process. The CD
spectra obtained for HPA3 and HPA3P in liposome solution showed
that the proline substitution prevented HPA3P from adopting
secondary structure in the zwitterionic DMPC membrane and the
helical content increased in the presence of negatively charged DMPGmolecules. Various studies have shown the important role of
electrostatics and bilayer thickness on peptide binding to membranes
and these results demonstrate that the negative charge on the
membrane surface has a signiﬁcant effect on the induction of HPA3
and HPA3P helical structure.
The physicochemical properties associated with HPA3 and HPA3P
interaction with DMPC and DMPC/DMPG SLBs were quantitatively
characterised in terms of their mass bound to different lipid bilayers,
extent of changes in membrane molecular ordering as a function of
peptide mass and impact on the structural properties of membrane
bilayers throughout the entire interaction process. A signiﬁcant aspect
of this study is the ability to fully characterise each single planar
bilayer system in terms of a range of dynamic structural parameters
including thickness/density, mass, lipid surface area and orientational
order. This degree of quantitative characterisation of the bilayer
structure enables the real-time action of peptides to be accurately
probed in terms of alterations in the dynamic structure of the bilayer.
The values for the thickness, mass, density and lipid orientational
order of the DMPC membrane prior to peptide binding were smaller
than those for the binary DMPC/DMPG membrane. These results
when taken together with the smaller area per lipid for DMPC/DMPG
(Table 2) indicate a higher packing density for DMPC/DMPG mixed
bilayers compared to DMPC membranes, which is consistent with
other negatively chargedmixed bilayers [52,53]. These results suggest
that the DMPC/DMPG bilayer adopts a more ordered alignment of the
fatty acyl chains than the pure DMPC bilayer [32].
With respect to the binding of HPA3 to these bilayers, the SPR
binding proﬁles were similar on both DMPC and DMPC/DMPG
bilayers in terms of the amount bound and the residual peptide
bound after dissociation. However, further probing of this interaction
by DPI revealed signiﬁcant differences in the effect of HPA3 on the two
phospholipid bilayers. In particular, the degree of DMPC/DMPG
bilayer disruption was double that observed for DMPC upon binding
of HPA3. Moreover, the temperature denaturation of DMPC/DMPG
was signiﬁcantly compromised compared to DMPC. These results
clearly demonstrate that the presence of negatively charged phos-
pholipids enhances the ability of HPA3 to bind and insert into the
membrane and are consistent with data previously obtained from
ﬂuorescence quenching studies [25]. Speciﬁcally, the less effective
quenching of tryptophan ﬂuorescence with anionic lipid vesicles
compared to zwitterionic lipid vesicles suggested that HPA3 is buried
more extensively in the anionic membrane. In particular, HPA3 has
been shown to translocate through the membrane [30,31] and the
higher SPR response may reﬂect a certain degree of translocation
which is not possible with the DPI surface.
Comparison of the binding behaviour of HPA3 with HPA3P also
revealed signiﬁcant differences and highlighted the inﬂuence of the
proline substitution. The SPR proﬁles revealed a much lower level of
binding of HPA3P compared to HPA3. Such large difference in SPR
response as a result of introducing proline is not seen between
binding to DMPC and DMPC/DMPG. However, while birefringence
analysis revealed that HPA3P perturbed the DMPC bilayer less than
HPA3, the proline substitution resulted in as large a change in the
DMPC/DMPG bilayer structure as HPA3, even though HPA3P bound
much less to DMPC/DMPG. These results suggest that the electro-
static interaction between the positively charged face of the peptide
and the negatively charged head groups of DMPG facilitates the
hydrophobic helix patch insertion into the lipid acyl chain region
resulting in greater disordering of the bilayer matrix. HPA3 adopts a
linear helical structure while HPA3P is likely to have a kink in the
middle of the peptide caused by the proline substitution. The
decrease in the helical structure together with the proline-induced
kink has clearly exerted a signiﬁcant inﬂuence on the binding
mechanism. Firstly, the kink disrupted the hydrophobic membrane
binding/insertion face (lower retention time and lower amount
bound on both membranes). Secondly, once bound and inserted into
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of bilayer disruption per unit peptide mass as it cannot be easily
accommodated by the aligned phospholipid chains and cannot
translocate through the bilayer.
Overall, these changes in birefringence provide insight into the
speciﬁc steps associated with the binding of the HPA3 peptides. While
it is hard to draw any direct correlations between binding data and
cytolytic properties, we can conclude that these peptides have
signiﬁcantly different binding properties and that these differences
relate to differences in the effect on membrane structure. Fig. 9 shows
a schematic diagram of these steps for both HPA3 and HPA3P. In
general, the initial event in peptide–membrane interactions is the
association of peptide with a large excess of phospholipid. During this
surface interaction, as shown in Fig. 9B, only a small degree of changes
in membrane birefringence is measured at low peptide mass. At
sufﬁciently high concentration, the peptides may change their
orientation by inserting vertically or at an oblique angle into the
lipid bilayer, forming pores of either barrel stave or toroidal type,
although the speciﬁc angle of the peptide relative to the bilayer
normal cannot be determined by DPI (Fig. 9C). After this initial event,
the peptide can either dissociate leaving the membrane intact or
penetrate the bilayer. A signiﬁcant degree of membrane perturbation
and disruption can then take place and is generally described in terms
of a detergent-like carpet mechanism, the induction of non-lamellar
lipid phases, or the formation of discrete pores. While the nature ofFig. 9. Schematic of the membrane interaction of the HPA3 peptides depicting the
changes in bilayer order as measured by birefringence. (A) An ordered membrane with
fully aligned lipid acyl chains where Δnf is about 0.022; (B) the binding of peptides to
the bilayer surface changes the order of the lipid head group resulting in a small
decrease in the Δnf to 0.0216 and (C) the insertion of the peptide partially or fully into
the bilayer destroys the lipid acyl chain packing and results in large changes in the
degree of ordering resulting in a large decrease in the Δnf to 0.0180. The birefringence
(Δnf ) values obtained for DMPC bilayer at 20 °C were used as examples.the pore structure cannot be explicitly determined by DPI, peptides
undergo signiﬁcant structural changes upon interaction with mem-
branes which can include oligomerisation. The question of whether a
peptide oligomerises within the membrane to form a distinct pore is
very difﬁcult to determine and is often assumed to occur based on for
example, dye leakage experiments. While oligomerisation can play a
signiﬁcant role for some antimicrobial peptides, and is required to
provide a full mechanistic description of peptide disruption, the focus
of this paper is the structure of the membrane, irrespective of the
oligomerisation state of the peptide. The unique feature of DPI is that
it allows us to focus on the bilayer structure and provides a mea-
surement of the membrane birefringence (anisotropy) which is the
difference in the refractive index of two different polarised lights (TM
and TE). This is a fully quantitative measurement of the lipid packing
and ordering of the whole membrane matrix. What the DPI ex-
periments then allow is the direct real-time measurement of the
peptide-induced changes to and/or disruption of the bilayer structure
which is of primary importance in understanding the molecular
mechanisms of antimicrobial peptide action.
Thus, while it has been shown by leakage and electrophysiology
studies [30,31] that the HPA3 peptides form pores, the ability to follow
the process by which the pore is formed in terms of changes in bilayer
structure allows a signiﬁcantly more detailed description of HPA3
action. In particular, it is not only the end result of binding/insertion/
disruption that is important (i.e. pore or carpet), but also the pro-
gressive mechanism by which that ﬁnal stage is reached that
needs to be elucidated. Overall, we have shown that the impact of
the Hp(2–20) peptides on membrane structure can be monitored in
real-time. However, the action of many cytolytic peptides is associ-
ated with loss of material from the support surface including previous
studies by our group [65]. While the HPA peptides do not exhibit this
behaviour on this system, the results of experiments characterising
peptide-induced mass loss and a range of membrane-disruptive
behaviour will be reported elsewhere. Nevertheless, the results even
with only two peptides demonstrate that the mechanisms of bilayer
disturbance differ signiﬁcantly between two very well characterised
phospholipids. Given the enormous range of membrane-active pep-
tides and the associated biological and biophysical properties, the
results of our study combined with the results of other biophysical
techniques such as ﬂuorescence, Fourier transform infra-red spec-
troscopy, atomic force microscopy and NMR, will provide a new
approach to characterising antimicrobial peptides and will further
improve the design and development of effective peptide antibiotics.Acknowledgements
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